These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24521290)

  • 1. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
    Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
    Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
    Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
    Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
    Matsuo A; Hamada H; Takahashi H; Okamoto A; Kaise H; Chikazu D
    Odontology; 2016 Sep; 104(3):363-71. PubMed ID: 25956267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
    Nicolatou-Galitis O; Papadopoulou E; Sarri T; Boziari P; Karayianni A; Kyrtsonis MC; Repousis P; Barbounis V; Migliorati CA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):195-202. PubMed ID: 21622014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
    Koth VS; Figueiredo MA; Salum FG; Cherubini K
    Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T; Bryant C; Popat S
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
    Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
    Thumbigere-Math V; Michalowicz BS; Hughes PJ; Basi DL; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
    J Oral Maxillofac Surg; 2016 Apr; 74(4):738-46. PubMed ID: 26501428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.
    Saia G; Blandamura S; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Bedogni A
    J Oral Maxillofac Surg; 2010 Apr; 68(4):797-804. PubMed ID: 20307765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Survey on Bisphosphonate-Related Osteonecrosis of the Jaws in Japan.
    Shibahara T; Morikawa T; Yago K; Kishimoto H; Imai Y; Kurita K
    J Oral Maxillofac Surg; 2018 Oct; 76(10):2105-2112. PubMed ID: 29746838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.